Recent trends in prescription drug misuse in the United States by age, race/ethnicity, and sex

BACKGROUND AND OBJECTIVES: To examine changes in United States past‐year opioid, stimulant, and benzodiazepine prescription drug misuse (PDM) and poly‐PDM by demographics. METHODS: Data were from the 2015–2019 National Survey on Drug Use and Health (N = 282,768), examining annualized PDM change by d...

Descripción completa

Detalles Bibliográficos
Autores principales: Schepis, Ty S., McCabe, Sean E., Ford, Jason A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463082/
https://www.ncbi.nlm.nih.gov/pubmed/35441439
http://dx.doi.org/10.1111/ajad.13289
Descripción
Sumario:BACKGROUND AND OBJECTIVES: To examine changes in United States past‐year opioid, stimulant, and benzodiazepine prescription drug misuse (PDM) and poly‐PDM by demographics. METHODS: Data were from the 2015–2019 National Survey on Drug Use and Health (N = 282,768), examining annualized PDM change by demographics. RESULTS: Opioid and poly‐PDM significantly declined among those under 35 years, White, and multiracial residents. DISCUSSION AND CONCLUSIONS: Age and race/ethnicity are important moderators of recent PDM trends, warranting investigation of mechanisms. SCIENTIFIC SIGNIFICANCE: Results highlight ongoing PDM declines in younger groups but expand the literature by showing limited changes in adults 35 and older and non‐opioid PDM.

Ejemplares similares